Bimatoprost + Timolol Genetic, 0.3 mg/ml + 5 mg/ml, eye drops, solution,
in a single-dose container
Bimatoprostum + Timololum
What is it used for
Bimatoprost + Timolol Genetic single-dose contains two active substances (bimatoprost and timolol) that lower intraocular pressure. Bimatoprost belongs to a group of medicines called prostamides, prostaglandin analogs. Timolol belongs to a group of medicines called beta-blockers.
The eye contains a clear, watery fluid that nourishes the inside of the eye. The fluid is constantly drained from the eye and replaced by new fluid. If the fluid cannot be drained quickly enough, the pressure in the eye increases, which can eventually lead to vision damage (causing a disease called glaucoma). The action of Bimatoprost + Timolol Genetic single-dose is to reduce the production of fluid and increase the amount of drained fluid. This leads to a decrease in intraocular pressure.
Bimatoprost + Timolol Genetic single-dose eye drops are used to treat high pressure in the eye in adults, including the elderly. High pressure can lead to glaucoma. The doctor will prescribe Bimatoprost + Timolol Genetic single-dose when the action of other eye drops containing beta-blockers or prostaglandin analogs is insufficient.
Contraindications
Before starting to use this medicine, the patient should discuss it with their doctor if they currently have or have had any of the following conditions:
Before anesthesia for surgery, the patient should tell their doctor about using Bimatoprost + Timolol Genetic single-dose, as timolol may affect the action of some anesthetics.
Bimatoprost + Timolol Genetic single-dose may cause darkening and excessive growth of eyelashes, as well as darkening of the skin around the eye. Over time, it may also darken the color of the iris. These changes may be permanent. Changes may be more noticeable when treating only one eye. If Bimatoprost + Timolol Genetic single-dose comes into contact with the skin surface, it may cause hair growth.
Bimatoprost + Timolol Genetic single-dose should not be used in children and adolescents under 18 years of age.
Other medicines may affect the action of Bimatoprost + Timolol Genetic single-dose, and Bimatoprost + Timolol Genetic single-dose may affect the action of other medicines, including other eye drops used to treat glaucoma. The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. The patient should tell their doctor about taking or planning to take medicines that lower blood pressure, heart disease medicines, diabetes medicines, quinidine (a medicine used for heart diseases or certain types of malaria) or medicines used to treat depression known as fluoxetine and paroxetine.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine. Bimatoprost + Timolol Genetic single-dose should not be used during pregnancy, unless the doctor recommends otherwise.
Bimatoprost + Timolol Genetic single-dose should not be used during breastfeeding. Timolol may pass into breast milk.
Before taking any medicine during breastfeeding, the patient should consult their doctor.
Bimatoprost + Timolol Genetic single-dose may cause blurred vision in some patients. The patient should not drive vehicles or operate machines until the symptoms have resolved.
This medicine contains 0.96 mg of phosphates in each ml of solution.
(See section 4. Other side effects reported during the use of eye drops containing phosphates).
This medicine should always be used exactly as the doctor or pharmacist has told the patient. In case of doubts, the patient should consult their doctor or pharmacist.
The recommended dose is one drop into each eye that needs treatment, once a day, in the morning or evening. The medicine should be used every day at the same time.
Before use, the patient should wash their hands. Before use, the patient should make sure that the single-dose container is intact. The solution should be used immediately after opening the container. To prevent contamination, the patient should not touch the open end of the container to the eye or anything else.
If the drop does not get into the eye, the patient should try again. The patient should wipe off any excess medicine that runs onto the cheek.
If the patient wears contact lenses, they should remove them before using this medicine. After using the medicine, the patient should wait 15 minutes before putting the lenses back in.
The patient should wait at least 5 minutes between instilling Bimatoprost + Timolol Genetic single-dose and administering another medicine. Eye ointment or eye gel should be applied last.
In case of using a higher dose of Bimatoprost + Timolol Genetic single-dose than recommended, it is unlikely to cause serious harm.
The next dose should be taken at the usual time. In case of doubts, the patient should consult their doctor or pharmacist.
In case of missing a dose of Bimatoprost + Timolol Genetic single-dose, the patient should take a single drop as soon as they remember, and then continue using the medicine as planned. The patient should not take a double dose to make up for the missed dose.
To work properly, Bimatoprost + Timolol Genetic single-dose should be used every day.
In case of any further doubts about using this medicine, the patient should consult their doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Usually, the patient can continue using the eye drops if the side effects are not severe. In case of doubts, the patient should consult their doctor or pharmacist. The patient should not stop using Bimatoprost + Timolol Genetic single-dose without consulting their doctor.
The following side effects may occur during the use of Bimatoprost + Timolol Genetic (in both multi-dose and single-dose forms):
Very common side effects(may affect more than 1 in 10 people)
Eye disorders
redness.
Common side effects(may affect up to 1 in 10 people)
Eye disorders
burning sensation, itching, stinging, irritation of the conjunctiva (the transparent membrane covering the eye), sensitivity to light, eye pain, stickiness of the eye, dryness of the eye, feeling of a foreign body in the eye, minor damage to the surface of the eye (with or without inflammation), blurred vision,
redness and itching of the eyelids, hair growth around the eye, darkening of the eyelids, darker skin tone around the eyes, elongation of eyelashes, eye irritation, excessive tearing, swelling of the eyelids, limited vision.
Other disorders
runny nose, headache.
Uncommon side effects(may affect up to 1 in 100 people)
Eye disorders
abnormal sensations in the eye, inflammation of the iris, swelling of the conjunctiva (the transparent membrane of the eye), eyelid pain, eye fatigue, ingrown eyelashes, darkening of the iris, feeling of sunken eyes, eyelid margin abnormality, darkening of eyelashes.
Other disorders
shortness of breath.
Eye disorders
cystoid macular edema (retinal edema leading to vision impairment), eye swelling, blurred vision, eye discomfort.
Other disorders
breathing difficulties / wheezing, symptoms of allergic reactions (swelling, redness of the eye, and skin rash), taste disorders, dizziness, slow heart rate, high blood pressure, sleep disorders, nightmares, asthma, hair loss, skin color changes (around the eyes), fatigue.
Other side effects have been observed in patients using eye drops containing timolol or bimatoprost, and may therefore occur when using Bimatoprost + Timolol Genetic. Like other ophthalmic beta-blockers, timolol may become systemic and cause similar side effects as seen with systemic beta-adrenergic blockade. The frequency of systemic side effects after topical ophthalmic administration is lower than for systemic administration. These side effects include:
Other side effects reported with the use of eye drops containing phosphates
If the patient has severe damage to the transparent layer of the eyeball (cornea), phosphates may rarely cause the appearance of cloudy spots on the cornea due to calcium deposits during treatment.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should consult their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: 22 49-21-301
fax: 22 49-21-309
Website: https://smz.ezdrowie.gov.pl .
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the single-dose container, sachet, and carton after "Exp". The expiry date refers to the last day of the month.
This medicine is for single use only and does not contain preservatives. Do not store unused solution.
There are no special storage instructions for this medicine. Single-dose containers should be stored in the sachet and carton to protect from light. Shelf life after first opening of the sachet - 7 days.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
Bimatoprost + Timolol Genetic single-dose is a colorless, clear solution supplied in single-dose containers containing 0.4 ml of solution.
Packs contain 6 foil sachets, each containing 5 single-dose containers – a total of 30 single-dose containers.
Genetic S.p.A.
Via G. Della Monica 26
84083 Castel San Giorgio (SA)
Italy
Genetic S.p.A.
Contrada Canfora 84084 Fisciano (SA)
Italy
To obtain more detailed information, the patient should contact the representative of the marketing authorization holder:
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.